MGMT and cancer: Tumors with high MGMT expression often exhibit resistance to alkylating chemotherapeutic agents such as temozolomide (TMZ), carmustine (BCNU), and lomustine (CCNU), which rely on unrepaired DNA lesions to trigger cancer cell death [4, 5].